How to buy IRIDEX Corporation stock (IRIX)

IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.74 – an increase of 1.75% over the previous week. IRIDEX Corporation employs 111 staff and has a trailing 12-month revenue of around $48.4 million.

Our top picks for where to buy IRIDEX Corporation stock

Buy IRIDEX Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

IRIDEX Corporation stock price (NASDAQ: IRIX)

Use our graph to track the performance of IRIX stocks over time.

IRIDEX Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$1.74
52-week range	$1.27 - $3.65
50-day moving average more info button	$1.64
200-day moving average more info button	$2.16
Wall St. target price	$2.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.67

Is it a good time to buy IRIDEX Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IRIDEX Corporation price performance over time

Historical closes compared with the close of $1.74 from 2024-12-24

1 week (2024-12-19)	1.75%
1 month (2024-11-26)	-1.69%
3 months (2024-09-26)	-3.33%
6 months (2024-06-26)	-21.27%

1 year (2023-12-26)	-30.95%
2 years (2022-12-23)	-17.54%
3 years (2021-12-23)	6.22
5 years (2019-12-26)	2.44

IRIDEX Corporation financials

Revenue TTM	$48.4 million
Gross profit TTM	$25.4 million
Return on assets TTM	-20.89%
Return on equity TTM	-150.28%
Profit margin	-22.79%
Book value	$0.16
Market Capitalization more info button	$27.3 million

TTM: trailing 12 months

IRIDEX Corporation share dividends

We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.

IRIDEX Corporation share price volatility

Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $1.2717 up to $3.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 0.811. This would suggest that IRIDEX Corporation's shares are less volatile than average (for this exchange).

IRIDEX Corporation overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc.

Frequently asked questions

What percentage of IRIDEX Corporation is owned by insiders or institutions?
Currently 20.67% of IRIDEX Corporation shares are held by insiders and 20.058% by institutions. How many people work for IRIDEX Corporation?
Latest data suggests 111 work at IRIDEX Corporation. When does the fiscal year end for IRIDEX Corporation?
IRIDEX Corporation's fiscal year ends in December. Where is IRIDEX Corporation based?
IRIDEX Corporation's address is: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043 What is IRIDEX Corporation's ISIN number?
IRIDEX Corporation's international securities identification number is: US4626841013 What is IRIDEX Corporation's CUSIP number?
IRIDEX Corporation's Committee on Uniform Securities Identification Procedures number is: 462684101